Applied Molecular Transport Inc. AMTI:NASDAQ

Last Price$14.84NASDAQ Previous Close - Last Trade as of 4:00PM ET 12/03/21
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$14.18 (1)
Ask (Size)$19.40 (1)
Day Low / HighN/A - N/A
Volume659.4 K

Read more news Recent News

Applied Molecular Transport Reports Positive Additional Data From Phase 1b Trial of AMT-101 to Treat UC Patients
8:44AM ET 7/09/2021 MT Newswires

Applied Molecular Transport (AMTI) reported additional positive data from a phase 1b trial of oral AMT-101 in ulcerative colitis patients. The...

Applied Molecular Transport Prices Share Offering at $42/Share, Expects to Raise $105 Million
3:44AM ET 4/01/2021 MT Newswires

Applied Molecular Transport (AMTI) priced a public offering of 2.5 million common shares at $42.00 per share, for gross proceeds of about $105 million,...

Applied Molecular Transport Begins 2.5 Million Share Offering
4:33PM ET 3/29/2021 MT Newswires

Applied Molecular Transport (AMTI) said Monday it started a public offering of 2.5 million shares. Another 375,000 shares are set aside for overallotments,...

--Analyst Actions: Jefferies Adjusts Price Target on Applied Molecular Transport to $75 From $38, Maintains Buy Rating
8:37AM ET 3/23/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Company Profile

Business Description
Number of EmployeesN/A
Recent SEC Filing11/18/20214

Company Highlights

Price Open$16.03
Previous Close$16.09
52 Week Range$14.50 - 78.22
Market Capitalization$571.2 M
Shares Outstanding38.5 M
SectorHealth Technology
Next Earnings Announcement03/18/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$2.42
Beta vs. S&P 500N/A
Net Profit MarginN/A
Return on Equity-55.65%

Analyst Ratings as of 04/05/2021

Consensus RecommendationConsensus Icon
Powered by Factset